Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-25-028597

Options or other derivatives

  • Chief Executive Officer acquired 8,629 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. Chief Executive Officer 2025-12-18 Grant or award · Stock Option (Right to Buy) +8,629 $4.20 $36,242 157,668 D
Loading xslF345X05/ownership.xml…